Articles On Telix Pharmaceuticals (ASX:TLX)
| Title | Source | Codes | Date |
|---|---|---|---|
|
‘Highly Accurate’: Telix’s Phase III ZIRCON Trial for Kidney Cancer Imaging Published in The Lancet Oncology
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, Sept. 11, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited... |
FNArena | TLX | 1 year ago |
|
Two ASX 200 Shares to Watch Today: Mineral Resources Ltd (ASX: MIN) and Telix Pharmaceuticals Ltd (ASX: TLX)
Investors are keeping a close eye on several S&P/ASX 200 Index (ASX: XJO) shares, with two particular stocks standing out for their potential to outperform. These two companies represent different sectors—one in mining and the other in... |
Kalkine Media | TLX | 1 year ago |
|
2 compelling ASX 200 shares to buy today
Below, we look at two compelling S&P/ASX 200 Index (ASX: XJO) shares you may wish to consider adding to your portfolio. One stock has been under intense selling pressure in 2024 while the other has seen its share price rocket. And David... |
Motley Fool | TLX | 1 year ago |
|
FNArena Corporate Results Monitor – 06-09-2024
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Welcome to the FNArena Corporate Results Monitor. Today’s Reports: ((AIS)) – Aeris... |
FNArena | TLX | 1 year ago |
|
ASX up 0.17% near noon: Commodities mixed
Australian shares opened higher, buoyed by a rise in tech stocks, particularly Tesla and Amazon, which lifted the Nasdaq amid mixed performance on Wall Street. At 11:35am, the S&P/ASX 200 is 0.17 per cent higher at 7,995.60, with four o... |
ShareCafe | TLX | 1 year ago |
|
IPAX-1 Study of TLX101 Investigational Glioblastoma Therapy Published in Neuro-Oncology Advances
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, Sept. 4, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited... |
FNArena | TLX | 1 year ago |
|
Alive and Kicking: Noxopharm has difficult brain cancer in its sights
Noxopharm says two novel drug candidates significantly reduced glioblastoma (brain cancer) cell growth in preclinical models. Percheron Therapeutics announces “very encouraging” new data for its epilepsy program Cyclopharm is off to a soli... |
Stockhead | TLX | 1 year ago |
|
ASX down 0.3% near noon contrasting with S&P500
In the first session of the week, the Australian sharemarket is experiencing a decline, primarily driven by weakness in mining and communications stocks. By midday, the S&P/ASX 200 index is down 0.3 per cent, hovering near 8067 points.... |
ShareCafe | TLX | 1 year ago |
|
Dr Boreham’s Crucible: Diverse ASX biotech gun Telix brushes off suggestions its peaked
Telix Pharmaceuticals (ASX:TLX) CEO and co-founder Dr Chris Behrenbruch is blunt about why some fund managers believe the ASX market darling is entering ‘overvalued’ territory. “The fundies probably hate [us] because they didn’t get their a... |
Stockhead | TLX | 1 year ago |
|
The Overnight Report: No Nvidia Fireworks
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Looks like the local market is set for yet again a weaker opening on Thursday. Wor... |
FNArena | TLX | 1 year ago |
|
ASX closes flat as Woolworths reports results
The Australian share market closed flat on Wednesday, with consumer staples offsetting losses in commodity stocks. Woolworths' strong earnings boosted the consumer staples sector, while lower iron ore and uranium prices weighed on mining an... |
ShareCafe | TLX | 1 year ago |
|
Telix wins fast track status from US FDA for new brain cancer PET scan imaging agent
Telix Pharmaceuticals (ASX:TLX) has announced its receipt of fast track status from the US FDA within the approvals chain for the assessment of Telix’s PET-scan brain cancer imaging agent Pixclara. The company is focusing particularly on... |
themarketonline.com.au | TLX | 1 year ago |
|
Telix Submits NDA for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, Aug. 28, 2024 /PRNewswire/ – Telix Pharmaceuticals Limited... |
FNArena | TLX | 1 year ago |
|
The Overnight Report: Waiting For Nvidia
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin World Overnight SPI Overnight 7996.00 – 29.00 – 0.36% S&P ASX 200 8071.20... |
FNArena | TLX | 1 year ago |
|
Telix shares extend gains amid 'evolving' leadership changes
Telix Pharmaceuticals Ltd (ASX: TLX) shares are drifting higher on Tuesday, extending gains to 98% for the year to date. Shares in the biopharmaceutical company are swapping hands less than 1% higher at $19.90 apiece at the time of publ... |
Motley Fool | TLX | 1 year ago |
|
Telix Announces Reorganisation to Deliver on Strategic Priorities
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, Aug. 27, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited... |
FNArena | TLX | 1 year ago |
|
The Overnight Report: BHP, Coles & Woodside
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin World Overnight SPI Overnight 8041.00 + 4.00 0.05% S&P ASX 200 8084.50 + 6... |
FNArena | TLX | 1 year ago |
|
Closing Bell: Windy day for stocks as ANZ, Tabcorp get stung by regulators
ASX ended 10-day winning streak ANZ, Tabcorp dropped after facing regulators Despite a crude price rebound, energy stocks fell The ASX 200 ended its 10-day winning streak, dipping by 0.04% after a weak session on Wall Street overnight.... |
Stockhead | TLX | 1 year ago |
|
Why Fund Managers Are Growing Discontented with These 10 ASX Stars
For chief executives and institutional investors, the critical phase of earnings season begins after the analyst calls, media interviews, and the presentation of results have concluded. Investor roadshows offer a unique opportunity for fund... |
Kalkine Media | TLX | 1 year ago |
|
Australian Shares Set to End 10-Day Winning Streak
Australian shares are poised to end a 10-day winning streak on Friday, with the market opening down 0.2 percent at 8008 points. This decline follows a negative session on Wall Street, where the Nasdaq (NASDAQ:IXIC) experienced a drop of 1.7... |
Kalkine Media | TLX | 1 year ago |
|
Telix share price sinks 9% despite stellar half-year growth
The Telix Pharmaceuticals Ltd (ASX: TLX) share price is on the move on Friday morning. At the time of writing, the ASX 200 healthcare stock is down 9% to $18.04. This follows the release of its half-year results after the market close yeste... |
Motley Fool | TLX | 1 year ago |
|
ASX 200 Sees Modest Gains, Market Eyes Friday Session
On Thursday, the S&P/ASX 200 Index (ASX: XJO) recorded a modest gain, rising 0.2% to close at 8,027 points. As the market gears up for Friday’s session, several factors could influence the day's performance: ASX 200 Set for a Slight Di... |
Kalkine Media | TLX | 1 year ago |
|
5 things to watch on the ASX 200 on Friday
On Thursday, the S&P/ASX 200 Index (ASX: XJO) had another decent session and recorded a small gain. The benchmark index rose 0.2% to 8,027 points. Will the market be able to build on this on Friday and end the week on a high? Here are... |
Motley Fool | TLX | 1 year ago |
|
Telix 2024 Half-Year Results: Strong Commercial Revenue and Profit Growth to Support Strategic Priorities
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, Aug. 22, 2024 /PRNewswire/ — Telix Pharmaceuticals Limited... |
FNArena | TLX | 1 year ago |
|
ASX down 0.07% near noon: Consumer Staples is worst performing sector
At 11:40am, the S&P/ASX 200 is 0.07 per cent lower at 7,965.9, the Australian share market opened lower, influenced by a decline in consumer staples stocks. Investors reacted to a wave of company earnings released on Monday. A2 Milk exp... |
ShareCafe | TLX | 1 year ago |
|
ASX up 1.39% near noon: Investors respond to US retail sales data
At 11:30am, the S&P/ASX 200 is 1.39 per cent higher at 7,974.5, driven by optimism about potential interest rate cuts and robust economic data. Investors responded positively to strong US retail sales and positive GDP figures from Japan... |
ShareCafe | TLX | 1 year ago |
|
Rudi’s View: Model Portfolios, Best Ideas & Conviction Calls
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Rudi Filapek-Vandyck By Rudi Filapek-Vandyck, Editor Morningstar's Best Equity Ideas for A... |
FNArena | TLX | 1 year ago |
|
Why are ASX healthcare shares dragging on the ASX 200 today?
It's been a bouncy, yet positive session for the S&P/ASX 200 Index (ASX: XJO) and most ASX 200 shares so far this Tuesday. At the time of writing, the ASX 200 has added a decent 0.17%, putting the index at around 7,830 points. But it wo... |
Motley Fool | TLX | 1 year ago |
|
Which ASX 200 market sector has been the best performer over 10 years?
The S&P/ASX 200 Index (ASX: XJO) comprises 11 market sectors, and the outperformer over the past decade may surprise you. It's not the flashy tech sector, nor the sectors home to the mega-miners or the Big Four bank shares. I... |
Motley Fool | TLX | 1 year ago |
|
ASX up 0.2% near noon: RBA says no rate cuts this year
At 11:40am, the S&P/ASX 200 is 0.2 per cent higher at 7,695.60. Michele Bullock's calm and steady demeanor as a central banker is essential to mitigating market panic. She effectively reassured the market with the RBA's statement and he... |
ShareCafe | TLX | 1 year ago |
|
ASX up 0.2% near noon: Investors await for further economic indicators
The Australian sharemarket rebounded today after heavy selling yesterday. At noon, the S&P/ASX 200 is 0.2 per cent higher at 7,665. This rebound comes amid a broader global market upheaval triggered by growing concerns over a potential... |
ShareCafe | TLX | 1 year ago |
|
The Overnight Report: Fed Rate Cuts Are Coming
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin World Overnight SPI Overnight 8084.00 + 23.00 0.29% S&P ASX 200 8092.30 +... |
FNArena | TLX | 1 year ago |
|
ASX surges 1.8% driven by low inflation figures
The Australian sharemarket surged 1.8% on Wednesday, driven by unexpectedly low inflation figures, quashing expectations of a rate hike. All sectors experienced gains, led by consumer discretionary and materials stocks. Consumer confidence... |
ShareCafe | TLX | 1 year ago |
|
Up 86% in 2024, why is the Telix Pharmaceuticals share price tumbling today?
The Telix Pharmaceuticals Ltd (ASX: TLX) share price is taking a tumble today. Shares in the S&P/ASX 200 Index (ASX: XJO) biopharmaceutical company closed yesterday trading for $19.32. In early afternoon trade on Wednesday, shares a... |
Motley Fool | TLX | 1 year ago |
|
Why Brainchip, Gold Road, Mesoblast, and Telix shares are tumbling today
The S&P/ASX 200 Index (ASX: XJO) is on track to record a strong gain on Wednesday. At the time of writing, the benchmark index is up 1.2% to 8,050.1 points. Four ASX shares that have failed to follow the market higher today are listed... |
Motley Fool | TLX | 1 year ago |
|
ASX up 1.1% near noon: CPI increases to 3.8% in June quarter
Australian annual inflation increased to 3.8% in the June quarter, aligning with market expectations. While quarterly inflation remained steady at 1%, core inflation eased slightly. This data will significantly influence the Reserve Bank of... |
ShareCafe | TLX | 1 year ago |
|
2 ASX healthcare shares making splashes in the US
ASX healthcare shares are often touted here on the Australian share market. We are home to some of the most innovative players in the healthcare domain. But there's also a handful of companies that are growing their business over in the... |
Motley Fool | TLX | 1 year ago |
|
Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter
Nova Minerals (ASX:NVA) shares dipped nearly -3% in Friday morning trades after announcing it was closing the pre-listing IPO process for its new NASDAQ digs. The company is listing on the tech heavy stock market at a value of only US$3.... |
themarketonline.com.au | TLX | 1 year ago |
|
Here are the top 10 ASX 200 shares today
The S&P/ASX 200 Index (ASX: XJO) endured yet another red day this Thursday. Making it three losses from four this week, the ASX 200 fell by a nasty 1.29% by the closing bell this session, lea... |
Motley Fool | TLX | 1 year ago |
|
The Overnight Report: More Sellers Than Buyers
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin Looks like defensives are in vogue today when the local market opens, but all else m... |
FNArena | TLX | 1 year ago |
|
ASX falls 0.1%: Best performer is Materials
The Australian sharemarket fell on Wednesday, with the S&P/ASX 200 Index dropping 0.1% due to declines in energy and property stocks. Despite a rebound in crude oil prices, major energy companies like Woodside Energy, Ampol, and Viva En... |
ShareCafe | TLX | 1 year ago |
|
Reasons Behind the Decline in Argosy Minerals, Flight Centre, Mesoblast, and Telix Shares Today
The S&P/ASX 200 Index (ASX: XJO) is experiencing a lackluster session on Wednesday, with the benchmark index falling slightly to 7,967.4 points. Several ASX-listed shares are facing notable declines today, contributing to the overall do... |
Kalkine Media | TLX | 1 year ago |
|
Australian Shares Slip After US Market Decline
Australian shares experienced a decline at midday, following a downward trend in US markets. The benchmark S&P/ASX 200 Index fell by 0.1%, or 4.1 points, to 7967. This dip was influenced by losses in the ASX energy sector, reflecting th... |
Kalkine Media | TLX | 1 year ago |
|
ASX 200 Poised to Rise; US Futures Slip Amid Tesla, Alphabet Earnings and Pilbara Minerals Report
As of 8:30 am AEST, ASX 200 futures are trading 11 points higher, up 0.13%. Overnight, major US benchmarks ended slightly lower, with small-cap stocks outperforming. Alphabet reported its earnings after the bell, resulting in a 1.6% drop... |
Kalkine Media | TLX | 1 year ago |
|
Here are the top 10 ASX 200 shares today
The S&P/ASX 200 Index (ASX: XJO) endured a tough start to the trading week this Monday, continuing the market malaise we saw at the end of last week's trading. By the closing bell today, the A... |
Motley Fool | TLX | 1 year ago |
|
ASX falls 0.5% over concerns over Biden’s decision
On Monday, Australian shares declined due to concerns over the potential impact of US President Joe Biden’s decision to end his re-election campaign on financial markets. The S&P/ASX 200 Index fell 0.5% to 7931.7, with declines in minin... |
ShareCafe | TLX | 1 year ago |
|
ASX down 0.8% at noon: Investors react to Biden’s withdrawing from presidential race
Australian shares fell 0.8% at the open, influenced by upcoming US tech earnings and President Joe Biden’s decision to end his re-election campaign. The S&P/ASX 200 Index dropped by 62.5 points to 7909.1, with significant losses in mate... |
ShareCafe | TLX | 1 year ago |
|
ASX 200 falls as Domino’s (ASX:DMP) share price dumped on store closures
The S&P/ASX 200 (ASX: XJO) fell on Thursday, following a global lead that was driven by the selloff of technology and semiconductor names like NVIDIA (NASDAQ: NVDA). The technology sector fell 3.4 per cent, joining eight other sectors t... |
Rask Media | TLX | 1 year ago |
|
Key ASX 200 Updates to Watch for This Friday
The S&P/ASX 200 Index (ASX: XJO) experienced a slight setback on Thursday, ending its recent winning streak with a 0.3% decline to 8,036.5 points. As the week draws to a close, several key factors will influence whether the market can b... |
Kalkine Media | TLX | 1 year ago |
|
The Overnight Report: Risk Off
This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin World Overnight SPI Overnight 7930.00 – 87.00 – 1.09% S&P ASX 200 8036.50... |
FNArena | TLX | 1 year ago |